Antifungal Prophylaxis In Hematopoietic Stem Cell Transplant Recipients
Journal Title: Macedonian Journal of Medical Sciences (MJMS) - Year 2008, Vol 1, Issue 1
Abstract
Background. According to immunological deficit the period after hematopoietic stem cell transplantation (HSCT) can be divided in three phases: aplastic phase, phase of acute GVHD, and phase of chronic GVHD. Fungal infections are predominant in first, aplastic phase. Deep neutropenia and implantation of central venous catheter are two major risk factors contributing to infection. Aim. To retrospectively analyze fungal infections, fungal isolates and to compare success of different antifungal strategies during the first 30 days after HSCT. Material and methods. During a 7 year period (2000-2007), we have performed 128 HSCT in 120 patients with different hematological diseases. Male: 62 Female: 58. Median age: 34 years. Patients were treated in sterile room, conditioned with HEPA filters, and low microbes diet. Antifungal prophylaxis with Fluconazole 200mg, Itraconazole 200mg, or combination Fluconazole200/Itraconazole 200 (in high-risk patients) was administered from day 0 until day +100. Results. Patients treated with combination of Fluconazole200/Itraconazol200 have had only few oropharyngeal candidiasis, without signs of invasive fungal infection. There is no statistically significant difference between the prophylaxis with Fluconazole and Itraconazole, (p=0,302). Non-Albicans Candida is predominantly isolated funga (Non-Albicans Candida vs. Candida Albicans: 54% vs. 46%). There is no isolation of Aspergillus during the first phase after HSCT in our group of patients. Concluson. The rising incidence of invasive fungal infections and the currently problematic early diagnosis call for an intensive exploration of new drugs and further developments in diagnosis and treatment of invasive fungal infection.
Authors and Affiliations
Zlate Stojanoski| Hematology Clinic, Medical Faculty, University St’s Cyril and Methodius, Skopje, Aleksandra Pivkova| Hematology Clinic, Medical Faculty, University St’s Cyril and Methodius, Skopje, Sonja Genadieva-Stavrik| Hematology Clinic, Medical Faculty, University St’s Cyril and Methodius, Skopje, Lidija Cevreska| Hematology Clinic, Medical Faculty, University St’s Cyril and Methodius, Skopje, Milena Petrovska| Institute of Microbiology and Parazitology, Medical Faculty, University St’s Cyril and Methodius, Skopje, Republic of Macedonia, Borche Georgievski| Hematology Clinic, Medical Faculty, University St’s Cyril and Methodius, Skopje
Keywords
Related Articles
- EP ID EP8587
- DOI 10.3889/MJMS.1857-5773.2008.0002
- Views 473
- Downloads 25
S100B Protein in Serum as a Prognostic Marker for Brain Injury in Term Newborn Infants with Hypoxic Ischemic Encephalopathy - New Strategy for Early Brain Damage
Background: The aim was to investigate whether S100 in serum is a prognostic marker of cerebral injury in term newborn infants with hypoxic ischemic encephalopathy (HIE) after perinatal asphyxia. Material and Methods:...
Antipsychotic Augmentation with Venlafaxine for Treatment of Negative Symptoms in Chronic Schizophrenia - A Case Series
Negative symptoms represent a core feature in schizophrenia and the deficit syndrome in chronic schizophrenic patients is closely related to their poor outcome and global failure in community adaptation. Atypical antip...
Thyroid Dysfunction in Patients with Systemic Connective Tissue Disease
Background. Alterations in the circulating thyroid hormone concentrations constituting the euthyroid sick syndrome (ESS) are frequently associated with systemic non-thyroidal diseases such as systemic connective tissue...
Pharmacoeconomics
Aim: The aim of this review was to provide an overview of the terminology, technology and methodology of pharmacoeconomic evaluations. The choice is made because there is small number of reviews on this subject in Mace...
Prognostic Value of the Expression of p53 in Patients with Non-small Cell Lung Cancer
Background. The p53 gene is frequently mutated in non-small-cell lung cancer (NSCLC). However, the effect of p53 gene mutations on patient prognosis remains unclear. Aim. The aim of this study is to determine the assoc...